{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T00:05:52Z","timestamp":1785801952414,"version":"3.56.0"},"reference-count":55,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2010,10,28]],"date-time":"2010-10-28T00:00:00Z","timestamp":1288224000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oral Diseases"],"published-print":{"date-parts":[[2011,3]]},"abstract":"<jats:p> <jats:italic>Oral Diseases<\/jats:italic> (2011) <jats:bold>17<\/jats:bold>, 154\u2013161<\/jats:p><jats:p>Radioiodine (<jats:sup>131<\/jats:sup>I) is an important therapy for patients who have well\u2010differentiated thyroid cancer. However, <jats:sup>131<\/jats:sup>I may also result in side effects in multiple organs and glands. The glands that are frequently affected are the salivary glands with the major untoward effects including sialoadenitis and increased risk of second primary malignancy. This report will review sialoadenitis secondary to <jats:sup>131<\/jats:sup>I therapy including (1) proposed mechanisms, (2) incidence and clinical presentations, (3) possible approaches to improve prevention, (4) management, and (5) sequelae of sialoadenitis (e.g. xerostomia and salivary duct obstruction). A discussion of second primary malignancies is beyond the scope of this review. With a better understanding of the above, dentists, oral surgeons, otolaryngologists, endocrinologists, nuclear medicine physicians, and nuclear radiologists will be more likely to implement more effective preventive measures to reduce the incidence and severity of <jats:sup>131<\/jats:sup>I\u2010induced sialoadenitis, and if it does occur, to identify and treat sialoadenitis sooner, thereby potentially reducing not only the severity of the initial symptoms, but also the severity of subsequent sequelae.<\/jats:p>","DOI":"10.1111\/j.1601-0825.2010.01726.x","type":"journal-article","created":{"date-parts":[[2010,10,28]],"date-time":"2010-10-28T23:05:03Z","timestamp":1288307103000},"page":"154-161","source":"Crossref","is-referenced-by-count":90,"title":["Sialoadenitis secondary to <sup>131<\/sup>I therapy for well\u2010differentiated thyroid cancer"],"prefix":"10.1111","volume":"17","author":[{"given":"D","family":"Van Nostrand","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2010,10,28]]},"reference":[{"key":"e_1_2_7_2_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-0029-1230516"},{"key":"e_1_2_7_3_1","first-page":"1551","article-title":"Intermediate and long\u2010term side effects of high\u2010dose radioiodine therapy for thyroid carcinoma","volume":"39","author":"Alexander C","year":"1998","journal-title":"J Nucl Med"},{"key":"e_1_2_7_4_1","first-page":"755","article-title":"Sialadenitis following I\u2010131 therapy for thyroid carcinoma: Concise communication","volume":"25","author":"Allweiss P","year":"1984","journal-title":"J Nucl Med"},{"key":"e_1_2_7_5_1","first-page":"171","article-title":"The relation of radioiodine dosimetry to results and complications in the treatment of metastatic thyroid cancer","volume":"87","author":"Benua RS","year":"1962","journal-title":"AJR"},{"key":"e_1_2_7_6_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1601-0825.2000.tb00316.x"},{"key":"e_1_2_7_7_1","doi-asserted-by":"publisher","DOI":"10.1089\/cbr.1999.14.337"},{"key":"e_1_2_7_8_1","doi-asserted-by":"publisher","DOI":"10.1002\/lary.20140"},{"key":"e_1_2_7_9_1","doi-asserted-by":"publisher","DOI":"10.1259\/0007-1285-57-676-323"},{"key":"e_1_2_7_10_1","first-page":"2214","article-title":"Complications, sequela and dosimetry of iodine\u2010131 therapy for thyroid carcinoma","volume":"33","author":"Busnell DL","year":"1992","journal-title":"J Nucl Med"},{"key":"e_1_2_7_11_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2354.1997.00036.x"},{"key":"e_1_2_7_12_1","first-page":"274","volume-title":"The thyroid","author":"Donachi I","year":"1978"},{"key":"e_1_2_7_13_1","first-page":"108","article-title":"Dosing considerations with amifostine: a review of the literature and clinical experience","volume":"26","author":"Dorr RT","year":"1999","journal-title":"Semin Oncol"},{"key":"e_1_2_7_14_1","doi-asserted-by":"publisher","DOI":"10.1259\/0007-1285-59-697-45"},{"key":"e_1_2_7_15_1","first-page":"713","article-title":"Clinical trial of a saliva stimulating tablet SST","volume":"74","author":"Ericson T","year":"1982","journal-title":"Tandjakartidningen"},{"key":"e_1_2_7_16_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI102830"},{"key":"e_1_2_7_17_1","doi-asserted-by":"publisher","DOI":"10.1259\/0007-1285-30-352-210"},{"key":"e_1_2_7_18_1","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.108.061382"},{"key":"e_1_2_7_19_1","doi-asserted-by":"publisher","DOI":"10.3109\/02841869209088279"},{"key":"e_1_2_7_20_1","first-page":"624","article-title":"Application of radioactive iodine in therapy of Graves\u2019 disease","volume":"1","author":"Hertz S","year":"1942","journal-title":"J Clin Invest"},{"key":"e_1_2_7_21_1","first-page":"447","article-title":"Secretion of radioiodine in digestive juices and milk in man","volume":"11","author":"Honour AJ","year":"1952","journal-title":"Clin Sci"},{"key":"e_1_2_7_22_1","doi-asserted-by":"crossref","first-page":"4416","DOI":"10.1210\/endo.139.10.6329","article-title":"An immunohistochemical study of Na+\/I\u2010symporter in human thyroid tissues and salivary gland tissues","volume":"139","author":"Jhiang SM","year":"1998","journal-title":"Endocrinology"},{"key":"e_1_2_7_23_1","first-page":"15P","article-title":"Transient radiation effects following high dose I\u2010131 therapy for differentiated thyroid cancer (DTC)","volume":"35","author":"Kahn S","year":"1994","journal-title":"J Nucl Med"},{"key":"e_1_2_7_24_1","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2007.0191"},{"key":"e_1_2_7_25_1","first-page":"291P","article-title":"Can salivary gland uptakes on a diagnostic I\u2010131 scan predict acute salivary gland dysfunction in patients receiving radioiodine therapy for thyroid cancer?","volume":"5","author":"Kulkarni K","year":"2004","journal-title":"J Nucl Med"},{"key":"e_1_2_7_26_1","first-page":"2118","article-title":"Does lemon candy decreased salivary gland damage after radioiodine therapy for thyroid cancer?","volume":"46","author":"Lam MGEH","year":"2005","journal-title":"Letter to the editor. J Nucl Med"},{"key":"e_1_2_7_27_1","first-page":"1","article-title":"Controversies in the treatment of thyroid carcinoma: The New York Memorial Hospital approach","volume":"4","author":"Leeper R","year":"1982","journal-title":"Thyroid Today"},{"key":"e_1_2_7_28_1","doi-asserted-by":"publisher","DOI":"10.1097\/00003072-198704000-00014"},{"key":"e_1_2_7_29_1","doi-asserted-by":"publisher","DOI":"10.1097\/00003072-199610000-00006"},{"key":"e_1_2_7_30_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-009-1368-6"},{"key":"e_1_2_7_31_1","first-page":"318","article-title":"Effect of radioactive iodine therapy on parotid gland function","volume":"103","author":"Maier H","year":"1987","journal-title":"Otolaryngology"},{"key":"e_1_2_7_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0360-3016(96)80016-2"},{"key":"e_1_2_7_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0278-2391(99)90444-5"},{"key":"e_1_2_7_34_1","doi-asserted-by":"publisher","DOI":"10.1089\/105072503321582060"},{"key":"e_1_2_7_35_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.1960.tb49959.x"},{"key":"e_1_2_7_36_1","first-page":"17P","article-title":"Cevimeline hydrochloride hydate in treating salivary gland dysfunction following radioiodine therapy for thyroid cancer","volume":"45","author":"Nakada K","year":"2004","journal-title":"J Nucl Med"},{"key":"e_1_2_7_37_1","first-page":"261","article-title":"Dose lemon candy decrease salivary gland damage after radioiodine therapy for thyroid cancer?","volume":"46","author":"Nakada K","year":"2005","journal-title":"J Nucl Med"},{"key":"e_1_2_7_38_1","first-page":"386P","article-title":"Follow\u2010up study of side effects for iodine\u2010131 treatment in patients with differentiated thyroid cancer","volume":"5","author":"Pan MS","year":"2004","journal-title":"J Nucl Med"},{"key":"e_1_2_7_39_1","first-page":"238","article-title":"Advances in diagnosis and management of salivary gland diseases. [Medical Progress]","volume":"140","author":"Rice DH","year":"1984","journal-title":"West J Med"},{"key":"e_1_2_7_40_1","first-page":"349","article-title":"Gastric (and salivary) excretion of radioiodine in man (preliminary report)","volume":"7","author":"Schiff L","year":"1947","journal-title":"J Nat Cancer Inst"},{"key":"e_1_2_7_41_1","first-page":"308","article-title":"Some oral aspects of radioactive iodine therapy for thyroid disease","volume":"24","author":"Schneyer LH","year":"1954","journal-title":"NYJ Dent"},{"key":"e_1_2_7_42_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1946.02870490016004"},{"key":"e_1_2_7_43_1","first-page":"34","article-title":"Pharmacokinetics of amifostine: effects of dose and method of administration","volume":"26","author":"Shaw LM","year":"1999","journal-title":"Semin Oncol"},{"key":"e_1_2_7_44_1","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.107.049411"},{"key":"e_1_2_7_45_1","first-page":"738","article-title":"Salivary and lacrimal gland dysfunction (sicca syndrome) after radioiodine therapy","volume":"42","author":"Solans R","year":"2001","journal-title":"J Nucl Med"},{"key":"e_1_2_7_46_1","first-page":"816","article-title":"Sialadenitis following iodine\u2010131 therapy for thyroid carcinoma","volume":"26","author":"Spiegel W","year":"1985","journal-title":"J Nucl Med"},{"key":"e_1_2_7_47_1","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(196408)17:8<1035::AID-CNCR2820170810>3.0.CO;2-W"},{"key":"e_1_2_7_48_1","doi-asserted-by":"publisher","DOI":"10.1259\/0007-1285-48-575-894"},{"key":"e_1_2_7_49_1","first-page":"699","article-title":"Protection of normal tissues by WR\u20102721 during fractionated irradiation","volume":"1","author":"Utley JF","year":"1976","journal-title":"AACN Clin Issues"},{"key":"e_1_2_7_50_1","first-page":"1005","article-title":"Salivary gland protection with sialagogues","volume":"19","author":"Van Nostrand D","year":"2009","journal-title":"A Case Report. Thyroid"},{"key":"e_1_2_7_51_1","doi-asserted-by":"crossref","unstructured":"Van NostrandD BandaruV ChennupatiV et al.(2010).Reduction of radiation absorbed dose to the parotid glands after the administration of lemon juice. In press","DOI":"10.1089\/thy.2009.0429"},{"key":"e_1_2_7_52_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-59259-995-0_52"},{"key":"e_1_2_7_53_1","first-page":"1519","article-title":"Side effects of \u201crational dose\u201d iodine\u2010131 therapy for metastatic well differentiated thyroid carcinoma","volume":"27","author":"Van Nostrand DV","year":"1986","journal-title":"J Nucl Med"},{"key":"e_1_2_7_54_1","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.107.042192"},{"key":"e_1_2_7_55_1","first-page":"129","article-title":"Future development of amifostine as a radioprotectant","volume":"26","author":"Werner\u2010Wasik M","year":"1999","journal-title":"Semin Oncol"},{"key":"e_1_2_7_56_1","doi-asserted-by":"publisher","DOI":"10.1097\/RLU.0b013e3181c7bfb2"}],"container-title":["Oral Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1601-0825.2010.01726.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1601-0825.2010.01726.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,31]],"date-time":"2023-10-31T21:08:32Z","timestamp":1698786512000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1601-0825.2010.01726.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,10,28]]},"references-count":55,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,3]]}},"alternative-id":["10.1111\/j.1601-0825.2010.01726.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1601-0825.2010.01726.x","archive":["Portico"],"relation":{},"ISSN":["1354-523X","1601-0825"],"issn-type":[{"value":"1354-523X","type":"print"},{"value":"1601-0825","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,10,28]]}}}